Denis Katz MD

Erstellt neuen Artikel

10 w

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development | #denis Katz medical affairs

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development

From syndromes to signatures: how precision biomarkers and regulatory strategy are rewiring CNS drug development and reducing late-stage failure.

Gefällt mir

Kommentar

hat sein Profilbild geändert

10 w

Gefällt mir

Kommentar

Mehr Beiträge laden

Männlich
Beiträge 2

08/21/90
Lebt in Vereinigte Staaten (USA)
Wohnt in United States
https://salienceclinical.com/

Über Uns

AAV-mediated delivery of enzymes, neurotransmitter-modulating proteins, or neurotrophic factors has been extensively explored in Parkinson’s disease. While early studies suggested biological activity, several randomized controlled trials failed to meet primary clinical endpoints, highlighting the challenges of placebo effects, target engagement, and disease heterogeneity.

Alben

(0)

Freunde

(0)

Gefällt mir

(0)

Gruppen

(0)

10 w

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development

10 w

Sprache